Savoring Intervention for Inflammation
(SAVOR Trial)
Trial Summary
What is the purpose of this trial?
This study aims to evaluate how savoring influences reward and threat processes and downstream inflammation. Savoring is designed to enhance positive affect, which may blunt stress responses and reduce downstream inflammation. The investigators aim to examine changes in the brain following the savoring intervention. The investigators are particularly interested in changes in brain activity that are correlated with changes in inflammation-related markers in the blood. In this single-armed pilot trial, the investigators will assess how savoring alters reactivity to rewarding and threatening experiences, and then examine related changes in downstream inflammation. The investigators intend to recruit 20 undergraduate students to complete a 7-week standardized savoring intervention. Participants will complete brain scans, daily diaries, questionnaires, a behavioral task, and blood collection at pre- and post-intervention assessments.
Do I need to stop taking my current medications to join the trial?
Yes, you may need to stop taking certain medications. The trial excludes participants who have used medications that influence inflammation in the last 6 months, bupropion, dopaminergic or neuroleptic medications in the last 6 months, and those currently using heterocyclics and SSRIs unless stabilized for at least 3 months.
What data supports the idea that Savoring Intervention for Inflammation is an effective treatment?
The available research shows that incorporating savoring into mindfulness-based interventions can improve outcomes related to positive feelings and well-being, especially in treating addiction. This suggests savoring might help reduce cravings, which is important for managing addiction. Additionally, mindfulness practices, including savoring, have shown promise in improving emotional balance and eating regulation, as seen in studies on mindful eating. These findings indicate that savoring interventions can be effective in enhancing overall well-being and self-regulation.12345
What safety data exists for the Savoring Intervention treatment?
The provided research does not directly address safety data for the Savoring Intervention or related mindfulness-based interventions. The studies focus on the potential benefits and mechanisms of mindfulness and savoring practices, particularly in relation to addiction, weight management, and emotional well-being. However, they do not provide specific safety data or report on adverse effects related to these interventions.12567
Is the Savoring Intervention a promising treatment for inflammation?
The Savoring Intervention, which helps people focus on and enjoy positive experiences, shows promise in improving well-being and resilience in older adults. It has also been effective in boosting happiness and reducing depressive symptoms. While the research doesn't directly link it to reducing inflammation, its positive effects on mental health suggest it could be a valuable treatment for overall well-being.89101112
Eligibility Criteria
This trial is for undergraduate students who may be experiencing inflammation and depression. They will participate in a savoring intervention designed to enhance positive feelings and potentially reduce stress-related inflammation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Savoring Intervention
Participants undergo a 7-week savoring intervention designed to enhance positive affect and reduce inflammation
Follow-up
Participants are monitored for changes in inflammation and psychological wellbeing post-intervention
Treatment Details
Interventions
- Savoring Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
Network for Emotional Wellbeing
Collaborator
National Institute on Aging (NIA)
Collaborator
National Institutes of Health (NIH)
Collaborator